The prognostic value of Skp2 expression in Egyptian diffuse large B-cell lymphoma

Applied Immunohistochemistry and Molecular Morphology

Volumn 20, Issue 1, 2012, Pages 47-55

  Abdou, Asmaa Gaber ^a   Asaad, Nancy Youssef ^a   Abd El Wahed, Moshira Mohammed ^a   Samaka, Rehab Monir ^a   Gad Allah, Marwa Salah ^a  

^a MENOUFIA UNIVERSITY   (Egypt)

Author keywords

diffuse large B cell lymphoma; Ki 67; necrosis; p27; prognosis; Skp2

Indexed keywords

PROTEIN P27; S PHASE KINASE ASSOCIATED PROTEIN 2;

ADOLESCENT; ADULT; ADVANCED CANCER; AGED; ARTICLE; CANCER GROWTH; CANCER SURVIVAL; CONTROLLED STUDY; DISEASE FREE INTERVAL; DISEASE FREE SURVIVAL; EGYPT; FEMALE; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; LARGE CELL LYMPHOMA; LYMPHOID HYPERPLASIA; MALE; MITOSIS; NECROSIS; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CELL PROLIFERATION; DISEASE-FREE SURVIVAL; EGYPT; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOHISTOCHEMISTRY; LYMPHOMA, LARGE B-CELL, DIFFUSE; MALE; MIDDLE AGED; S-PHASE KINASE-ASSOCIATED PROTEINS; SURVIVAL RATE;

EID: 83655192096     PISSN: 15412016     EISSN: 15334058     Source Type: Journal    
DOI: 10.1097/PAI.0b013e318219a19f     Document Type: Article

References (37)

1. Morton LM, Wang SS, Devesa SS, et al. Lymphoma incidence patterns by WHO subtype in the United States, 1992-2001. Blood 2006;107:265-276. (Pubitemid 43053551)
2. Mokhtar N, Gouda I, Adel I. eds. Lympho-hematopiotic system tumours. In: Mokhtar N, Gouda I, Adel I, eds. Cancer Pathology Registry. 2003-2004 and Time Trend Analysis. 1st ed. Cairo: NCI, Elsheraa press; 2007:46-55.
3. López-Guillermo A, Colomo L, Jiménez M, et al. Diffuse large B-cell lymphoma: clinical and biological characterization and outcome according to the nodal or extranodal primary origin. J Clin Oncol. 2005;23:2797-2804. (Pubitemid 46179470)
4. Hunt KE, Reichard KK. Diffuse large B-cell lymphoma. Arch Pathol Lab Med. 2008;132:118-124.
5. Chiarle R, Fan Y, Piva R, et al. S-phase kinase-associated protein 2 expression in non-Hodgkins lymphoma inversely correlates with p27 expression and defines cells in S phase. Am J Pathol. 2002;160:1457-1466. (Pubitemid 34411648)
6. Seki R, Okamura T, Koga H, et al. Prognostic significance of the F-box protein Skp2 expression in diffuse large B-cell lymphoma. Am J Hematol. 2003;73:230-235. (Pubitemid 36898878)
7. Latres E, Chiarle R, Schulman BA, et al. Role of the F-box protein Skp2 in lymphomagenesis. Proc Natl Acad Sci U S A. 2001;98: 2515-2520. (Pubitemid 32209513)
8. Fujita T, Liu W, Doihara H, et al. Regulation of Skp2-p27 axis by the Cdh1/anaphase-promoting complex pathway in colorectal tumorigenesis. Am J Pathol. 2008;173:217-228. (Pubitemid 351947969)
9. Kitagawa M, Lee SH, McCormick F. Skp2 suppresses p53- dependent apoptosis by inhibiting p300. Mol Cell 2008;29:217-231. (Pubitemid 351172826)
10. Reed SI. Deathproof: new insights on the role of skp2 in tumorigenesis. Cancer Cell. 2008;13:88-89. (Pubitemid 351175660)
11. Lim MS, Adamson A, Lin Z, et al. Expression of Skp2, a p27Kip1 ubiquitin ligase, in malignant lymphoma: correlation with p27Kip1 and proliferation index. Blood. 2002;100:2950-2956.
12. Davidovich S, Ben-Izhak O, Shapira M, et al. Over-expression of Skp2 is associated with resistance to preoperative doxorubicin-based chemotherapy in primary breast cancer. Breast Cancer Res 2008; 10:R63.
13. Seki R, Ohshima K, Fujisaki T, et al. Prognostic significance of S-phase kinase-associated protein 2 and p27kip1 in patients with diffuse large B-cell lymphoma: effects of rituximab. Ann Oncol. 2010;21:833-841.
14. Uddin S, Hussain A, Ahmed M, et al. S-phase kinase protein 2 is an attractive therapeutic target in a subset of diffuse large B-cell lymphoma. J Pathol. 2008;216:483-494.
15. Gurbuxani S, Anastasi J, Hyjek E. Diffuse large B-cell lymphoma- more than a diffuse collection of large B cells: an entity in search of a meaningful classification. Arch Pathol Lab Med. 2009;133: 1121-1134.
16. Hershko D, Bornstein G, Ben-Izhak O, et al. Inverse relation between levels of p27(Kip1) and of its ubiquitin ligase subunit Skp2 in colorectal carcinomas. Cancer. 2001;91:1745-1751. (Pubitemid 32377961)
17. Kudo Y, Kitajima S, Sato S, et al. High expression of S-phase kinase-interacting protein 2, human F-box protein, correlates with poor prognosis in oral squamous cell carcinomas. Cancer Res. 2001; 61:7044-7047. (Pubitemid 32946493)
18. Gao D, Inuzuka H, Tseng A, et al. Phosphorylation by Akt1 promotes cytoplasmic localization of Skp2 and impairs APCCdh1- mediated Skp2 destruction. Nat Cell Biol. 2009;11:397-408.
19. Li Q, Murphy M, Ross J, et al. Skp2 and p27kip1 expression in melanocytic nevi and melanoma: an inverse relationship. J Cutan Pathol. 2004;31: 633-642. (Pubitemid 39440843)
20. Drobnjak M, Melamed J, Taneja S, et al. Altered expression of p27 and Skp2 proteins in prostate cancer of African-American patients. Clin Cancer Res. 2003;9:2613-2619. (Pubitemid 36842104)
21. Ganiatsas S, Dow R, Thompson A, et al. A splice variant of Skp2 is retained in the cytoplasm and fails to direct cyclin D1 ubiquitination in the uterine cancer cell line SK-UT. Oncogene. 2001;20:3641-3650. (Pubitemid 32624956)
22. Slingerland J, Pagano M. Regulation of the Cdk inhibitor p27 and its deregulation in cancer. J Cell Physiol. 2000;183:10-17. (Pubitemid 30130220)
23. Frost V, Al-Mehairi S, Sinclair AJ. Exploitation of a non-apoptotic caspase to regulate the abundance of the cdkI p27(KIP1) in transformed lymphoid cells. Oncogene. 2001;20:2737-2748. (Pubitemid 32549831)
24. Wang IC, Chen YJ, Hughes D, et al. Forkhead box M1 regulates the transcriptional network of genes essential for mitotic progression and genes encoding the SCF (Skp2-Cks1) ubiquitin ligase. Mol Cell Biol. 2005;25:10875-11094.
25. Li SH, Li CF, Sung MT, et al. Skp2 is an independent prognosticator of gallbladder carcinoma among p27Kip1-interacting cell cycle regulators: an immunohistochemical study of 62 cases by tissue microarray. Mod Pathol. 2007;20:497-507.
26. Oliveira AM, Okuno SH, Nascimento AG, et al. Skp2 protein expression in soft tissue sarcomas. J Clin Oncol. 2003;21:722-727. (Pubitemid 46621909)
27. Gerdes J, Lemke H, Baisch H, et al. Cell cycle analysis of a cell proliferation-associated human nuclear antigen defined by the monoclonal antibody Ki-67. J Immunol. 1984;133:1710-1715. (Pubitemid 14035254)
28. Carrano AC, Pagano M. Role of the F-Box Protein Skp2 in adhesion-dependent cell cycle progression. J Cell Biol. 2001;153: 1381-1390.
29. Zhang H, Kobayashi R, Galaktionov K, et al. p19Skp1 and p45Skp2 are essential elements of the cyclin A-CDK2 S phase kinase. Cell. 1995;82:915-925.
30. Liu Z, Fu Q, Lv J, et al. Prognostic implication of p27Kip1, Skp2 and Cks1 expression in renal cell carcinoma: a tissue microarray study. J Exp Clin Cancer Res. 2008;27:51.
31. Lee SE, Hong SK, Han BK, et al. Prognostic significance of tumor necrosis in primary transitional cell carcinoma of upper urinary tract. Jpn J Clin Oncol. 2007;37:49-55. (Pubitemid 47090723)
32. Gordan JD, Lal P, Dondeti VR, et al. HIF-α effects on c-Myc distinguish two subtypes of sporadic VHL-deficient clear cell renal carcinoma. Cancer Cell 2008;14:435-446.
33. Dong Y, Sui L, Watanabe Y, et al. S-phase kinase-associated protein 2 expression in laryngeal squamous cell carcinomas and its prognostic implications. Oncol Rep 2003;10:321-325.
34. Shintani S, Li C, Mihara M, et al. Skp2 and Jab1 expression are associated with inverse expression of p27(KIP1) and poor prognosis in oral squamous cell carcinomas. Oncology. 2003;65: 355-362. (Pubitemid 38064948)
35. Yokoi S, Yasui K, Mori M, et al. Amplification and overexpression of Skp2 are associated with metastasis of non-small-cell lung cancers to lymph nodes. Am J Pathol. 2004;165:175-180. (Pubitemid 38821825)
36. Hung W, Tseng W, Shiea J, et al. Skp2 overexpression increases the expression ofMMP-2 and MMP-9 and invasion of lung cancer cells. Cancer Lett. 2010;288:156-161.
37. Dowen SE, Neutze DM, Pett MR, et al. Amplification of chromosome 5p correlates with increased expression of Skp2 in HPV-immortalized keratinocytes. Oncogene. 2003;22:2531-2540. (Pubitemid 36560735)